Anaphylaxis alert – Allerject Recall

Sanofi–aventis Canada Inc., in consultation with Health Canada, is recalling all lots of Allerject (0.15 mg/0.15mL and 0.3 mg/0.3 mL strength epinephrine auto-injectors) from the Canadian market. A similar recall is taking place in the United States, where it’s sold as Auvi-Q. I contacted Food Allergy Canada and they indicated that this recall is a voluntary recall from the company which shows how cautious they are being.  

This is the second recall of this product this year.  As someone that has a child with a peanut allergy – this concerns me greatly and for now on we will make sure our own child has at least one EpiPen until we see a full year of no recalls of this product.  You should consult with your doctor if you should still be using Allerject for the future.  This is a personal decision.

At camp we still use EpiPens because until we see a new product out with no issues for quite some time we feel its the safest approach.  No doubt they will improve this product as it is so convenient but for now we will be taking a cautious approach.

 

Mark Diamond

Camp Director 

Leave a Reply